Contents
Some European countries have decided not to vaccinate with AstraZeneka entirely due to a very rare side effect – cases of thrombosis and thrombocytopenia. Britain made a slightly different decision. As the latest data shows, it is right.
- At the turn of March and April, we had to deal with a kind of panic related to rare cases of thrombosis and thrombocytopenia in people vaccinated with AstraZeneka
- Part of the countries. without waiting for the opinion of the European Medicines Agency, it suspended the administration of this preparation against COVID-19
- Ultimately, when the EMA confirmed that it could be a very rare side effect after administration of the preparation, some countries dropped the vaccine. Britain only changed the age limit. There, the preparation is given to people over 40 years of age.
- More information can be found on the Onet homepage.
Thrombosis after AstraZeneka in Great Britain. Not a single case
From the announcement issued by the European Medicines Agency in April this year. shows that thrombosis and thrombocytopenia may be very rare side effects following the administration of AstraZeneki. EMA analyzed cases of such incidents among patients and concluded that they primarily affect young women.
Although it was emphasized all the time that the disease was extremely rare, and that the benefits of using AstraZeneki outweighed the potential risks, the reluctance to take the preparation grew. Fewer and fewer people decided to use AstraZeneka, and other countries decided not to use it at all. Unused stocks were sent to African countries, which, bearing in mind the media storm, were also reluctant to give it to their citizens.
- See also: This is what the unvaccinated are most afraid of. How many serious NOPs were there? [WE CHECK]
The British, however, decided to remain stoic. They did not stop administering the AstraZeneki vaccine, but only made a modification in terms of the target group. Given that thrombosis mainly affects young people, they raised the age limit. Today, only those citizens over 40 receive the vaccine in the UK.
The effect of such action is fully measurable and indicates that Great Britain made the right decision. There has not been a single case of thrombosis with thrombocytopenia in this country for several weeks.
Do you want to test your COVID-19 immunity after vaccination? Have you been infected and want to check your antibody levels? See the COVID-19 immunity test package, which you will perform at Diagnostics network points.
Thrombosis after AstraZeneka. How many such cases have occurred in Poland?
Poles did not stop vaccinating with AstraZeneka, but in June citizens could only sign up for the second dose of the preparation. As government representatives explained, it was related to the uncertainty of supplies. At the same time, they denied rumors that Poland had completely given up on vaccinating its citizens with this preparation.
Citizens of our country, like representatives of other nations, also feared thrombosis following vaccination against COVID-19. Is it right? As in other countries, also in Poland the percentage of similar cases was marginal. From the report of the National Institute of Public Health on August 4, we learn that from December 27, 2020, when the first dose of the COVID-19 vaccine was administered in Poland, thrombosis occurred in only a few dozen people. It was exactly 30 cases.
Thrombosis also occurred in 23 people vaccinated with Pfizer and two who received Moderny. After the Johnson & Johnson vaccine, only two cases have also been reported.
As emphasized by the EMA, and now confirmed by the data cited by Reuters, this is a marginal phenomenon and should not discourage in the least from vaccination with a preparation of proven efficacy and safety.
Also read:
- COVID-19 in Israel: Serious Cases Are on the Rise. «It doubled in 10 days»
- Who in Poland suffers from COVID-19 the most? Min. Niedzielski comments
- New York: over 200% more hospitalizations. The number of people suffering from COVID-19 is rapidly growing
- How is COVID-19 most common now? [WE EXPLAIN]
- How long does immunity last from COVID-19 vaccines? [WE EXPLAIN]
The content of the medTvoiLokony website is intended to improve, not replace, the contact between the Website User and their doctor. The website is intended for informational and educational purposes only. Before following the specialist knowledge, in particular medical advice, contained on our Website, you must consult a doctor. The Administrator does not bear any consequences resulting from the use of information contained on the Website. Do you need a medical consultation or an e-prescription? Go to halodoctor.pl, where you will get online help – quickly, safely and without leaving your home.